Drug Type Small molecule drug |
Synonyms SP-1154 |
Target |
Action inhibitors |
Mechanism TGF-β inhibitors(Transforming growth factor beta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H38N2O6 |
InChIKeyJNAHENHIPLWVOM-QIFFELNGSA-N |
CAS Registry2413214-33-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metabolic Dysfunction Associated Steatohepatitis | Preclinical | South Korea | 01 Jan 2022 | |
| Obesity | Preclinical | South Korea | 01 Jan 2022 |





